Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

Meucci, Nicoletta; Cappellari, Alberto; Barbieri, Sergio; Scarlato, Guglielmo; Nobile-Orazio, Eduardo; Meucci, N; Cappellari, A; Barbieri, S; Scarlato, G; Nobile-Orazio, E
December 1997
Journal of Neurology, Neurosurgery & Psychiatry;Dec1997, Vol. 63 Issue 6, p765
Academic Journal
journal article
No abstract available.


Related Articles

  • New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy. Cats, Elisabeth A.; van der Pol, W.-Ludo; Piepers, Sanne; Notermans, Nicolette C.; van den Berg-Vos, Renske M.; van den Berg, Leonard H. // Journal of Neurology;Oct2008, Vol. 255 Issue 10, p1598 

    A letter to the editor is presented concerning the use of new liquid intravenous immunoglobulin in the treatment of multifocal motor neuropathy.

  • MMN: From Immunological Cross-Talk to Conduction Block. Harschnitz, Oliver; Jongbloed, Bas; Franssen, Hessel; Straver, Dirk; Pol, W.; Berg, Leonard // Journal of Clinical Immunology;Jul2014 Supplement, Vol. 34, p112 

    Multifocal motor neuropathy (MMN) is a rare inflammatory neuropathy characterized by progressive, asymmetric distal limb weakness and conduction block (CB). Clinically MMN is a pure motor neuropathy, which as such can mimic motor neuron disease. GM1-specific IgM antibodies are present in the...

  • Treatment of Inflammatory and Paraproteinemic Neuropathies. Monaco, Salvatore; Turri, Emanuela; Zanusso, Gianluigi; Maistrello, Barbara // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Jun2004, Vol. 4 Issue 2, p141 

    Acquired demyelinating and inflammatory neuropathies encompass a number of acute and chronic autoimmune conditions characterized by variable degrees of clinical involvement. These disorders, including Guillain-Barr� syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy...

  • Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects. Rajabally, Yusuf A. // Journal of Neurology, Neurosurgery & Psychiatry;Jun2014, Vol. 85 Issue 6, p631 

    Intravenous immunoglobulin therapy is of proven effect in chronic inflammatory neuropathies, including chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). In more recent years, there have been a number of anecdotal case reports and small series,...

  • Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Hughes, R.A.C. // Drugs;2002, Vol. 63 Issue 3, p275 

    This review briefly describes current concepts concerning the nosological status, pathogenesis and management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). CIDP is an uncommon variable disorder of unknown but probably autoimmune aetiology. The commonest form of CIDP causes...

  • Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies. Jacob, Saiju; Rajabally, Yusuf A. // Current Neuropharmacology;Dec2009, Vol. 7 Issue 4, p337 

    Intravenous immunoglobulins (IVIg) have been shown in a number of trials, to be an effective treatment for the three main types of inflammatory neuropathies: Guillain-Barr� Syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). IVIg...

  • Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome. Lenglet, Timoth&a#x00E9;e; Haroche, Julien; Schnuriger, Aurélie; Maisonobe, Thierry; Viala, Karine; Michel, Yanne; Chelbi, Farhat; Grabli, David; Seror, Paul; Garbarg-Chenon, Antoine; Amoura, Zahir; Bouche, Pierre // Journal of Neurology;Jul2011, Vol. 258 Issue 7, p1321 

    To describe the characteristics of peripheral neuropathy related to acute parvovirus B19 (B19V) infection. We reviewed clinical, electrophysiological and histological data of three patients with peripheral neuropathy and positive B19V detection (IgG, IgM and PCR) compatible with acute infection....

  • Multifocal motor neuropathy: review of a treatable immune mediated disorder. Rajabally, Y. A. // Postgraduate Medical Journal;Jun2008, Vol. 84 Issue 992, p287 

    Initially described only about 20 years ago, multifocal motor neuropathy (MMN) is a predominantly distal, mainly upper limb, asymmetrical, pure motor neuropathy. MMN is immune mediated, and frequently associated with antiganglioside antibodies to GM1 of lgM type. The hallmark of MMN is the...

  • IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results. Nobile-Orazio, Eduardo; Terenghi, Fabrizia // Journal of Neurology;May2005 Supplement 1, Vol. 252, pI7 

    High-dose intravenous immunoglobulin (IVIg) is effective in the treatment of idiopathic autoimmune neuropathies including Guillain-Barr� syndrome (GBS), chronic inflammatory demyelinating neuropathy (CIDP) and multifocal motor neuropathy (MMN), representing a useful option or, as in MMN,the...

  • Treatment of multifocal motor neuropathy. Nobile-Orazio, E.; Terenghi, F.; Carpo, M.; Bersano, A. // Neurological Sciences;Oct2003 Supplement 4, Vol. 24, pS251 

    Multifocal motor neuropathy (MMN) is a purely motor multineuropathy characterized by multifocal conduction blocks on motor nerves. The pathogenesis of MMN is not known but its frequent association with anti-ganglioside anti-bodies and the improvement after immune therapies support an immune...


Read the Article


Sign out of this library

Other Topics